8
Participants
Start Date
March 31, 2011
Primary Completion Date
August 31, 2015
Study Completion Date
December 31, 2015
Pasireotide
4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment with pasireotide LAR 60mg every 28 days with dose reductions if poor tolerability is encountered
Barts and the London NHS Trust, London
The Christie Hospital NHS Foundation Trust, Manchester
Oxford University Hospitals NHS Trust, Oxford
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Collaborators (1)
Novartis
INDUSTRY
The Christie NHS Foundation Trust
OTHER
Oxford University Hospitals NHS Trust
OTHER
Barts & The London NHS Trust
OTHER
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER